These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8695545)

  • 1. New drugs in the treatment of non-small cell lung cancer.
    Steward WP; Dunlop DJ
    Ann Oncol; 1995; 6 Suppl 1():49-54. PubMed ID: 8695545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New directions for chemotherapy in non-small-cell lung cancer.
    Green MR
    Chest; 1993 Apr; 103(4 Suppl):370S-372S. PubMed ID: 8096453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs in non-small cell lung cancer. An overview.
    Giaccone G
    Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New chemotherapeutic agents for non-small cell lung cancer.
    Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
    Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for non-small cell lung cancer: have we reached a new plateau?
    Shepherd FA
    Semin Oncol; 1999 Feb; 26(1 Suppl 4):3-11. PubMed ID: 10201515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising new agents in the treatment of non-small cell lung cancer.
    Edelman MJ; Gandara DR
    Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New promising anticancer drugs for lung cancer].
    Ariyoshi Y; Sugiura T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
    Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
    Saijo N
    Chest; 1998 Jan; 113(1 Suppl):17S-23S. PubMed ID: 9438685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New chemotherapy agents in the treatment of advanced non-small cell lung cancer: an update including data from the Seventh World Conference on Lung Cancer.
    Comis RL; Friedland DM
    Lung Cancer; 1995 Jun; 12 Suppl 2():S63-99. PubMed ID: 7551951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
    Meert AP; Berghmans T; Branle F; Lemaître F; Mascaux C; Rubesova E; Vermylen P; Paesmans M; Sculier JP
    Anticancer Res; 1999; 19(5C):4379-90. PubMed ID: 10650780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single agents in the second-line treatment of non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):10-4. PubMed ID: 9704670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New agents in the treatment of small cell lung cancer.
    Ghaemmaghami M; Jett JR
    Chest; 1998 Jan; 113(1 Suppl):86S-91S. PubMed ID: 9438696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Goss GD; Logan DM; Newman TE; Evans WK
    Cancer Prev Control; 1997; 1(1):28-38. PubMed ID: 9765724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.
    Hanada M; Noguchi T; Yamaoka T
    Cancer Sci; 2007 Mar; 98(3):447-54. PubMed ID: 17214744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of unresectable non-small cell lung cancer.
    Livingston RB
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):4-11; discussion 11-3. PubMed ID: 7973768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F; Helsberg K; Schütte WH; Leschinger MI
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.